Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 212-409-3 | CAS number: 814-89-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: inhalation
Administrative data
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2015-02-15 to 2016-03-17
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 436 (Acute Inhalation Toxicity: Acute Toxic Class Method)
- Version / remarks:
- 2009-09-07
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- signed 2014-05-14
- Test type:
- acute toxic class method
- Limit test:
- yes
Test material
- Reference substance name:
- Cobalt oxalate
- EC Number:
- 212-409-3
- EC Name:
- Cobalt oxalate
- Cas Number:
- 814-89-1
- Molecular formula:
- C2H2O4.Co
- IUPAC Name:
- cobalt(2+) oxalate
- Test material form:
- solid: particulate/powder
- Details on test material:
- - State of aggregation: pink powder
- Particle size distribution:
D10% = 1.24 μm
D50% = 4.50 μm
D90% = 20.23 μm
Constituent 1
- Specific details on test material used for the study:
- STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: container kept upright and tightly closed in a dry, cool and well-ventilated place, avoiding heat or direct sunlight.
Test animals
- Species:
- rat
- Strain:
- other: Crl: CD(SD)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories Research Models and Services Germany GmbH, Sulzfeld ,Germany
- Females nulliparous and non-pregnant: yes
- Age at study initiation: males: approx. 8 weeks; females: approx. 9 weeks
- Weight at study initiation: males: 257 - 280 g; females: 233 - 260 g
- Fasting period before study: feeding was discontinued approx. 16 hours before exposure; only tap water was then available ad libitum.
- Housing: kept by sex in groups of 3 animals (MAKROLON cages (type III plus)) during the 14-day observation period; bedding material: granulated textured wood (Granulat A2, J. Brandenburg, Goldenstedt, Germany)
- Diet: commercial diet, ssniff® R/M-H V1534 (ssniff Spezialdiäten GmbH, Soest, Germany)
- Water (ad libitum): drinking water
- Acclimation period: at least 5 adaptation days
Animals were acclimatised to the test apparatus for approx. 1 hour on 2 days prior to testing.
ENVIRONMENTAL CONDITIONS
- Temperature: 22°C ± 3°C (maximum range)
- Relative humidity: 55 % ± 15 % (maximum range)
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- inhalation: dust
- Type of inhalation exposure:
- nose only
- Vehicle:
- clean air
- Mass median aerodynamic diameter (MMAD):
- >= 1.9 - <= 1.974 µm
- Geometric standard deviation (GSD):
- >= 2.5 - <= 2.55
- Details on inhalation exposure:
- GENERATION OF TEST ATMOSPHERE / CHAMBER DESCRIPTION
- Exposure apparatus /exposure chamber volume: dynamic inhalation apparatus (RHEMA-LABORTECHNIK) (air changes/h (≥ 12times)) with a nose-only exposure of the animals according to KIMMERLE & TEPPER.
The apparatus consists of a cylindrical exposure chamber, which holds the animals in pyrex tubes at the edge of the chamber in a radial position.
Actual dimensions of the inhalation chamber: inner diameter: 28.2 cm; height: 64.6 cm; volume: 40.3 L
- System of generating particulates/aerosols: dust of the test item was generated using a rotating brush dust generator (RBG 1000, PALAS GmbH Partikel und Lasermesstechnik). The generator was fed with compressed air (5.0 bar) from a compressor (ALUP Kompressorenfabrik).
At the bottom of the exposure chamber, the air was sucked off at a lower flow rate than it was created by the dust generator in order to produce a homogenous distribution and a positive pressure in the exposure chamber (inflow 900 L/h, outflow 800 L/h).
A manometer and an air-flow meter (ROTA Yokogawa GmbH & Co. KG) were used to control the constant supply of compressed air and the exhaust, respectively. Flow rates were checked hourly and corrected if necessary.
- Method of particle size determination: an analysis of the particle size distribution was carried out twice during the exposure period using a cascade impactor 6.0 L/min (TSE Systems GmbH).
The dust from the exposure chamber was drawn through the cascade impactor for 1 minute (constant flow rate: 5 L/min). The slides were removed from the impactor and weighed on an analytical balance (Sartorius BP 121 S, 120 g weighing capacity, precision: 0.1 mg, resolution: 0.1 mg, linearity: 0.2 mg). Deltas of slides’ weight were determined.
The mass median aerodynamic diameter (MMAD) was estimated by means of non-linear regression analysis. The 10.6 μm particle size range and the filter (particle size range < 0.55 μm) were not included in the determination of the MMAD in order not to give undue weight to these values.
The Geometric Standard Deviation (GSD) of the MMAD was calculated from the quotient of the 84.1%- and the 50%-mass fractions, both obtained from the above mentioned non-linear regression analysis.
- Temperature, humidity, pressure in air chamber, oxygen content; carbon dioxide content: oxygen content in the inhalation chamber was 21% (determined at the beginning and at the end of the exposure; DRÄGER Oxygen-analysis test set)(DRÄGER Tube Oxygen 67 28 081). Carbon dioxide concentration did not exceed 1%.
Temperature (21.0°C ± 0.2°C (main study) or 21.1°C ± 0.1°C (satellite group)) and humidity (57.3% ± 0.1% (main study) or 51.4% ± 0.1% (satellite group)) were measured once every hour with a climate control monitor (testo 175-HZ data logger).
Exposition started by locating the animals into the exposure chamber after equilibration of the chamber concentration for at least 15 minutes (t95 approx. 8 minutes).
A pre-test was carried out with the exposure system in order to verify that under the experimental settings chosen, the limit concentration of 5 mg/L air could be achieved by gravimetric analysis.
TEST ATMOSPHERE
- Brief description of analytical method used: actual dust concentration in the inhalation chamber was measured gravimetrically with an air sample filter (Minisart SM 17598, 0.45 μm) and pump (Vacuubrand, MZ 2C) controlled by a rotameter. Dust samples were taken once every hour during the exposure. The filters were weighed before and after sampling (accuracy 0.1 mg).
- Samples taken from breathing zone: yes, at a constant flow of air of 5 L/min for 1 minute
Individual chamber concentration samples did not deviate from the mean chamber concentration by more than 1%. - Analytical verification of test atmosphere concentrations:
- yes
- Duration of exposure:
- 4 h
- Concentrations:
- Main study (limit test):
- actual concentration: 5.06 ± 0.01 mg/L air
- nominal concentration: 24.44 mg/L air
Satellite group:
- actual concentration: 5.06 ± 0.03 mg/L air
- nominal concentration: 24.44 mg/L air - No. of animals per sex per dose:
- Main study (limit test): 3 males / 3 females
Satellite group: 3 males / 3 females - Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 24 hours (satellite group) and 14 days (main study)
- Frequency of observations and weighing: during the exposure period the animals were observed frequently. Following exposure, observations were made at least twice on the day of exposure and at least once each day. Observations on mortality were made at least once daily (in the morning starting on test day 2).
Individual weights of animals were determined once during the acclimatisation period, before the exposure on test day 1, on test days 2, 4, 8 and 15. Changes in weight were calculated and recorded when survival exceeded one day. At the end of the test, all animals were weighed and sacrificed.
- Necropsy of survivors performed: yes
Necropsy of all main study and satellite animals was carried out and all gross pathological changes were recorded:
- satellite animals: necropsy at 24 hours after cessation of exposure
- main study animals: necropsy at the end of the 14-day observation period
All main study and satellite animals were subjected to histopathological examination upon necropsy at the end of the respective observation period. During histopathology, attention was paid to alterations that might be indicative of respiratory irritation, such as hyperaemia, oedema, minimal inflammation, and thickened mucous layer.
The following organs of all animals were fixed: nasal cavity (tip and 5 levels; tip and level 1: cut just anterior to the incisor teeth; level 2: cut approx. 2 mm posterior to free the tip of the
incisor teeth; level 3: cut through the incisive papilla; level 4: cut through the middle of the second palatal ridge, which is located just anterior to the molar teeth; level 5: cut through the middle of the molar teeth), nasopharynx, paranasal sinus, larynx, trachea, and lung.
The histopathology was conducted in consideration of the suggestions made in the OECD Guidance Document on Histopathology for Inhalation Toxicity Studies, Supporting TG 41 (Subacute Inhalation Toxicity: 28-day Study) and TG 413 (Subchronic Inhalation Toxicity: 90-day Study). OECD Series on Testing and Assessment No. 125, Document No. ENV/JM/MONO (2010) 16, June 01, 2010.
Assessment of respiratory tract irritation effects:
The assessment of respiratory tract irritation effects was conducted according to the criteria set forth in the OECD proposal document ENV/JM/HCL(2004)9/REV, where it is stated:
- There are currently no validated animal tests that deal specifically with respiratory tract irritation. However, useful information may be obtained from single and repeated inhalation toxicity tests. For example, animal studies may provide useful information in terms of toxicity (dyspnoea, rhinitis etc) and histopathology (e.g. hyperaemia, oedema, minimal inflammation, and thickened mucous layer) which are reversible and may be reflective of the characteristic clinical symptoms described above. Such animal studies can be used as part of weight of evidence evaluation.
- The special classification would occur only when more severe organ/systemic effects including the respiratory system were not observed. - Statistics:
- not applicable
Results and discussion
Effect levels
- Key result
- Sex:
- male/female
- Dose descriptor:
- LC50
- Effect level:
- > 5.06 mg/L air (analytical)
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Mortality:
- 5.06 mg/L air (main study) and 5.06 mg/L air (satellite group): no animal died prematurely.
- Clinical signs:
- other: 5.06 mg/L air (main study) and 5.06 mg/L air (satellite group): slight dyspnoea (reduced frequency of respiration with increased volume) immediately after end of exposure until 3 hours post exposure was observed in 3 of 3 male and 3 of 3 female animals of
- Body weight:
- 5.06 mg/L air (main study): all 3 of 3 male and 3 of 3 female animals appeared to be reduced in body weight gain throughout the whole recovery period.
- Gross pathology:
- No pathological findings were noted in the nasal cavity and in the lungs, neither for the main study animals (14-day sacrifice) nor for the satellite animals (24-hour sacrifice).
- Other findings:
- 1) Histopathology (test item related changes):
- 5.06 mg/L air (satellite group): the turbinates of levels 2 to 5 of the nasal cavities showed an acute mild to moderate focal degeneration of the olfactory epithelium with focal pyknosis, karyorrhexis and loss of olfactory epithelial cells. In the neighborhood of these defects a normal olfactory epithelium was detected.
Inflammatory cells were not noted near the degenerative olfactory epithelium. A normal respiratory epithelium partially with cilia was observed for the levels 2 to 5 of the nasal cavity. The respiratory epithelium contained three normal major cell types, the basal cells above the basement membrane, the ciliated epithelial cells and the secretory goblet cells.
2) Histopathology (not test item related changes):
- 5.06 mg/L air (main study) and 5.06 mg/L air (satellite group):
Nose (five levels): the nasal cavity and the turbinates of the nose of levels 1 to 5 showed a normal squamous and respiratory epithelium and a normal olfactory epithelium for levels 2 to 5. The olfactory epithelium of the main study rats showed a complete reversibility after a recovery of 14 days. The respiratory epithelium contained three normal major cell types, the basal cells above the basement membrane, the ciliated epithelial cells and the secretory goblet cells without degenerative or inflammatory reactions.
Lungs (five levels): all 5 lung localizations per animal of the satellite animals and the main study rats showed a minimal to mild alveolar haemorrhage and a minimal to mild focal atelectasis. These minimal changes are interpreted as spontaneous incidental findings within the normal range.
Trachea and larynx : the trachea and larynx showed a focal minimal to mild subepithelial lymphohistiocytic infiltration without degeneration of the epithelial cells. The number of seromocous glands in the larynx without inflammatory reactions was morphologically normal.
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- LC50 (male and female rats; 4 hours) > 5.06 mg/L air (actual concentration)
According to the EC-Regulation 1272/2008 and subsequent regulations, cobalt oxalate is not classified as acute toxic via the inhalation route.
Based on the results of the macroscopic and histopathological investigations, cobalt oxalate appears to be marginally irritating for the nasal cavities, confirmed by marginal histopathological changes in form of an acute mild to moderate focal degeneration of the focal olfactory epithelium. The changes observed were completely reversible during the 14-day recovery period.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.